Bad time in biotech - werkgeversreview Sales bij Benchling

3,0
21 jan 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Competitive OTE and provides a satisfying challenge.

Minpunten

Biotech market is bad right now and only 1 or 2 salespersons are hitting quota so nobody is making close to their OTE. Constant turnover in leadership and lack of consistent direction

Ontdek andere reviews over Benchling

5,0
16 dec 2025
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

1. Culture is great 2. Leadership is transparent 3. Business fundamentals are strong

Minpunten

1. Growing pains from being a mid stage company 2. Founders lack experience (but mitigate it well)

1
4,0
9 mrt 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The leader in the R&D software industry

Minpunten

Lots of change in the sales org in the past year - previously unclear in its mission

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle